Monitor the dynamic changes of GBM cell lines under TTFields treatment
RNA-seq (gene expression) · human · 52 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 52 samples: 19 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE270513_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1127441 and SRA study SRP515534. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 52 samples.
How we read this: 19 replicated groups read from 52 sample titles; they account for 52 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8345789 GBM cell line U87 Control cells without any treatment batch 1 replicate 1 GBM cell line U87 Contr…
- GSM8345790 GBM cell line U87 Control cells without any treatment batch 1 replicate 2 GBM cell line U87 Contr…
- GSM8345791 GBM cell line U87 Control cells without any treatment batch 1 replicate 3 GBM cell line U87 Contr…
- GSM8345792 GBM cell line LN428 Control cells without any treatment batch 1 replicate 1 GBM cell line LN428 Con…
- GSM8345793 GBM cell line LN428 Control cells without any treatment batch 1 replicate 2 GBM cell line LN428 Con…
- GSM8345794 GBM cell line LN428 Control cells without any treatment batch 1 replicate 3 GBM cell line LN428 Con…
- GSM8345795 GBM cell line LN827 Control cells without any treatment batch 1 replicate 1 GBM cell line LN827 Con…
- GSM8345796 GBM cell line LN827 Control cells without any treatment batch 1 replicate 2 GBM cell line LN827 Con…
- GSM8345797 GBM cell line LN827 Control cells without any treatment batch 1 replicate 3 GBM cell line LN827 Con…
- GSM8345798 GBM cell line U87 sensitive cells received TTFields less than 1 week batch 1 replicate 1 GBM cell line U87 sensi…
- GSM8345799 GBM cell line U87 sensitive cells received TTFields less than 1 week batch 1 replicate 2 GBM cell line U87 sensi…
- GSM8345800 GBM cell line U87 sensitive cells received TTFields less than 1 week batch 1 replicate 3 GBM cell line U87 sensi…
- GSM8345801 GBM cell line LN428 sensitive cells received TTFields less than 1 week batch 1 replicate 1 GBM cell line LN428 sen…
- GSM8345802 GBM cell line LN428 sensitive cells received TTFields less than 1 week batch 1 replicate 2 GBM cell line LN428 sen…
- GSM8345803 GBM cell line LN428 sensitive cells received TTFields less than 1 week batch 1 replicate 3 technical replicate 1 GBM cell line LN428 sen…
- GSM8345804 GBM cell line LN428 sensitive cells received TTFields less than 1 week batch 1 replicate 3 technical replicate 2 GBM cell line LN428 sen…
- GSM8345805 GBM cell line LN827 sensitive cells received TTFields less than 1 week batch 1 replicate 1 GBM cell line LN827 sen…
- GSM8345806 GBM cell line LN827 sensitive cells received TTFields less than 1 week batch 1 replicate 2 GBM cell line LN827 sen…
- GSM8345807 GBM cell line LN827 sensitive cells received TTFields less than 1 week batch 1 replicate 3 GBM cell line LN827 sen…
- GSM8345808 GBM cell line U87 resistant cells received TTFields more than 4 weeks batch 1 replicate 1 GBM cell line U87 resis…
- GSM8345809 GBM cell line U87 resistant cells received TTFields more than 4 weeks batch 1 replicate 2 GBM cell line U87 resis…
- GSM8345810 GBM cell line U87 resistant cells received TTFields more than 4 weeks batch 1 replicate 3 GBM cell line U87 resis…
- GSM8345811 GBM cell line LN428 resistant cells received TTFields more than 4 weeks batch 1 replicate 1 GBM cell line LN428 res…
- GSM8345812 GBM cell line LN428 resistant cells received TTFields more than 4 weeks batch 1 replicate 2 GBM cell line LN428 res…
- GSM8345813 GBM cell line LN428 resistant cells received TTFields more than 4 weeks batch 1 replicate 3 GBM cell line LN428 res…
- GSM8345814 GBM cell line LN827 resistant cells received TTFields more than 4 weeks batch 1 replicate 1 GBM cell line LN827 res…
- GSM8345815 GBM cell line LN827 resistant cells received TTFields more than 4 weeks batch 1 replicate 2 GBM cell line LN827 res…
- GSM8345816 GBM cell line LN827 resistant cells received TTFields more than 4 weeks batch 1 replicate 3 GBM cell line LN827 res…
- GSM8345817 GBM cell line U87 Control cells without any treatment batch 2 replicate 1 GBM cell line U87 Contr…
- GSM8345818 GBM cell line U87 Control cells without any treatment batch 2 replicate 2 GBM cell line U87 Contr…
- GSM8345819 GBM cell line U87 sensitive cells received TTFields for 6 hours batch 2 replicate 1 GBM cell line U87 sensi…
- GSM8345820 GBM cell line U87 sensitive cells received TTFields for 6 hours batch 2 replicate 2 GBM cell line U87 sensi…
- GSM8345821 GBM cell line U87 sensitive cells received TTFields for 6 hours batch 2 replicate 3 GBM cell line U87 sensi…
- GSM8345822 GBM cell line U87 sensitive cells received TTFields for 24 hours batch 2 replicate 1 GBM cell line U87 sensi…
- GSM8345823 GBM cell line U87 sensitive cells received TTFields for 24 hours batch 2 replicate 2 GBM cell line U87 sensi…
- GSM8345824 GBM cell line U87 sensitive cells received TTFields for 24 hours batch 2 replicate 3 GBM cell line U87 sensi…
- GSM8345825 GBM cell line LN428 Control cells without any treatment batch 2 replicate 1 GBM cell line LN428 Con…
- GSM8345826 GBM cell line LN428 Control cells without any treatment batch 2 replicate 2 GBM cell line LN428 Con…
- GSM8345827 GBM cell line LN428 sensitive cells received TTFields for 6 hours batch 2 replicate 1 GBM cell line LN428 sen…
- GSM8345828 GBM cell line LN428 sensitive cells received TTFields for 6 hours batch 2 replicate 2 GBM cell line LN428 sen…
+ 12 more — browse all 52 samples with per-sample file links →
- GSE222196 Treatment of prostate cancer cell lines with Androgen Receptor and Receptor Tyrosine Kinase inhibitors 246 samples shares treatment, lines
- GSE261334 Dynamics and single-cell transcriptomics of circulating immune cell populations in inflammatory bowel disease upon anti-integrin treatment 29 samples shares treatment, dynamic
- GSE245851 Transcriptomic analysis of human gastric cancer cell lines following T-DXd treatment 15 samples shares treatment, lines
- GSE334345 Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma 54 samples shares treatment, changes
- GSE264573 Single Cell Analysis of Treatment–Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies 4 samples shares treatment, changes
- GSE305389 Stromal and Endothelial Transcriptional Changes during Progression from MGUS to Myeloma and after Treatment Response [RNA-Seq] 25 samples shares treatment, changes
- GSE193525 TTFields plus TMZ treatment effects on newly diagnosed Glioblastoma patients in peripheral blood 24 samples shares treatment, ttfields
- GSE334189 RNA-seq analysis of global gene expression changes in human FSHD immortalized myotubes following treatment with the BAZ1A inhibitor C06 18 samples shares treatment, changes
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.